[Psychopathological correlates of dopaminergic dysfunction in alcoholic and schizophrenic patients]
- PMID: 10407835
- DOI: 10.1007/s001150050455
[Psychopathological correlates of dopaminergic dysfunction in alcoholic and schizophrenic patients]
Abstract
It has been suggested that anhedonia, the loss of pleasure, is associated with a dysfunction of the dopaminergic reward system in schizophrenic and alcohol-dependent patients. In a series of neuroendocrinological and brain imaging studies, we examined pre- and postsynaptic mechanisms of dopaminergic neurotransmission in non-human primates and in schizophrenic and alcohol-dependent patients. Among alcoholics, we found indicators of a sensitization of dopaminergic neurotransmission, which was associated with the relapse risk, but not with anhedonia or depression. Schizophrenics with neuroleptic blockade of striatal dopamine D2 receptors displayed psychomotor slowing and reduced motivation, but not anhedonia. Primate studies pointed to the importance of a temporocortical dysfunction in the pathogenesis of phasic dopaminergic dysregulation in the striatum. These observations indicate that a dysfunction of stimulus-dependent dopamine release may be associated with motivational deficits caused by a reduction in incentive salience, but not with anhedonia.
Similar articles
-
Dopaminergic dysfunction in schizophrenia: salience attribution revisited.Schizophr Bull. 2010 May;36(3):472-85. doi: 10.1093/schbul/sbq031. Epub 2010 May 7. Schizophr Bull. 2010. PMID: 20453041 Free PMC article. Review.
-
Dopaminergic dysfunction in alcoholism and schizophrenia--psychopathological and behavioral correlates.Eur Psychiatry. 2002 Mar;17(1):9-16. doi: 10.1016/s0924-9338(02)00628-4. Eur Psychiatry. 2002. PMID: 11918987 Review.
-
Anhedonia in schizophrenic, depressed, or alcohol-dependent patients--neurobiological correlates.Pharmacopsychiatry. 1994 Jul;27 Suppl 1:7-10. doi: 10.1055/s-2007-1014317. Pharmacopsychiatry. 1994. PMID: 7984706 Review.
-
Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence.Pharmacopsychiatry. 2001 Mar;34(2):66-72. doi: 10.1055/s-2001-15184. Pharmacopsychiatry. 2001. PMID: 11302566 Clinical Trial.
-
[Anhedonia--a general nosology surmounting correlate of a dysfunctional dopaminergic reward system?].Nervenarzt. 1999 May;70(5):391-8. doi: 10.1007/s001150050454. Nervenarzt. 1999. PMID: 10407834 Review. German.
Cited by
-
[Syndromal versus nosological diagnosis].Nervenarzt. 2013 Sep;84(9):1081-2, 1084-90. doi: 10.1007/s00115-012-3675-6. Nervenarzt. 2013. PMID: 23247993 Review. German.
-
Ventral striatum gray matter density reduction in patients with schizophrenia and psychotic emotional dysregulation.Neuroimage Clin. 2013 Dec 27;4:232-9. doi: 10.1016/j.nicl.2013.12.007. eCollection 2014. Neuroimage Clin. 2013. PMID: 24455473 Free PMC article.
-
Dopaminergic dysfunction in schizophrenia: salience attribution revisited.Schizophr Bull. 2010 May;36(3):472-85. doi: 10.1093/schbul/sbq031. Epub 2010 May 7. Schizophr Bull. 2010. PMID: 20453041 Free PMC article. Review.
-
The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia.Neurotox Res. 2006 Dec;10(3-4):235-52. doi: 10.1007/BF03033360. Neurotox Res. 2006. PMID: 17197373 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical